The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Asthma Information Papers
 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Leukotriene receptor antagonists: their therapeutic role in children with asthma

Home
Key Points
Introduction
Diagnostic considerations in young children
Rationale for leukotriene antagonism in childhood asthma
Clinical evidence for montelukast use in children
Preventive treatment in children
Other potential roles of LTRAs
Acknowledgements
References
Appendices
Content created June 2007
Page updated June 2007

Get Adobe Reader

Get Adobe Flash Player

ForwardBackAcknowledgements

This information paper was prepared in consultation with the following health professionals:

Professor Peter van Asperen, paediatric respiratory physician

Dr Kerry Hancock, general practitioner Professor Craig Mellis, paediatric respiratory physician

Ms Toni Riley, pharmacist

Professor Colin Robertson, paediatric respiratory physician

Other contributors:

Dr Sandra Anderson, respiratory scientist

Associate Professor Mimi Tang, paediatric allergist and immunologist

 

 

 

 

 

 

 

 

 

 

 

Top of page